Pharmacokinetics and bioequivalence of arbidol hydrochloride granules in human plasma

Chinese Pharmaceutical Journal

Volumn 41, Issue 23, 2006, Pages 1814-1817

  Ren, Yu Hong ^a   Sun, Jing Xia ^a   Jiang, Hong ^a   Shen, Jian Ping ^b   Zhang, Yin Di ^b   Zhang, Zheng Xing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Arbidol hydrochloride; Bioequivalence; HPLC; Pharmacokinetics

Indexed keywords

ARBIDOL; CYCLOHEXANE; SODIUM HYDROXIDE;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CALIBRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG GRANULE; DRUG STRUCTURE; FEMALE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 33846543037     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. RAINER M, PETER M, MONIKA F, et al. Sensitive high-performance liquid chromatographic determination of arbidol, a new antiviral compound, in human plasma[J]. J Chromatogr A, 1998, 810:63-69.